Tim McInerney
Director/Board Member at EMISPHERE TECHNOLOGIES, INC.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Michael Weiser | M | 61 |
Paramount BioCapital, Inc.
 Paramount BioCapital, Inc. Investment ManagersFinance Paramount BioCapital, Inc. is an alternative investment manager. The private company is based in New York, NY and has subsidiaries in the United States.
ZIOPHARM, Inc.
| 26 years |
| David Tanen | M | 52 |
Paramount BioCapital, Inc.
Paramount BioCapital, Inc. Investment ManagersFinance Paramount BioCapital, Inc. is an alternative investment manager. The private company is based in New York, NY and has subsidiaries in the United States.
Riverbank Capital Securities, Inc.
 Riverbank Capital Securities, Inc. Investment Banks/BrokersFinance Part of Two River Group Holdings LLC, Riverbank Capital Securities, Inc. deals securities. The company is based in New York, NY. | 9 years |
| Joshua Kazam | M | 47 |
Paramount BioCapital, Inc.
Paramount BioCapital, Inc. Investment ManagersFinance Paramount BioCapital, Inc. is an alternative investment manager. The private company is based in New York, NY and has subsidiaries in the United States.
Riverbank Capital Securities, Inc.
Riverbank Capital Securities, Inc. Investment Banks/BrokersFinance Part of Two River Group Holdings LLC, Riverbank Capital Securities, Inc. deals securities. The company is based in New York, NY. | 25 years |
| Timothy Rothwell | M | 73 | 15 years | |
| Peter Morgan Kash | M | 62 |
Paramount BioCapital, Inc.
Paramount BioCapital, Inc. Investment ManagersFinance Paramount BioCapital, Inc. is an alternative investment manager. The private company is based in New York, NY and has subsidiaries in the United States.
Riverbank Capital Securities, Inc.
Riverbank Capital Securities, Inc. Investment Banks/BrokersFinance Part of Two River Group Holdings LLC, Riverbank Capital Securities, Inc. deals securities. The company is based in New York, NY. | 13 years |
| Daniel DiPietro | M | - |
Paramount BioCapital, Inc.
Paramount BioCapital, Inc. Investment ManagersFinance Paramount BioCapital, Inc. is an alternative investment manager. The private company is based in New York, NY and has subsidiaries in the United States. | 19 years |
| Phil Nikolayuk | M | - | 9 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Richard Bagley | M | 80 |
ZIOPHARM, Inc.
| 8 years |
| Michael R. Garone | M | 66 | 9 years | |
| Tyler Cook | M | - | - | |
| Michael G. McGuinness | M | 70 | 5 years | |
| Jonathan Lewis | M | 65 |
ZIOPHARM, Inc.
| 11 years |
| James Cannon | M | 85 |
ZIOPHARM, Inc.
| 15 years |
| Robert Newman | M | - | 3 years | |
| Alan Rubino | M | 69 | 7 years | |
| Lewis Bender | M | 65 | 14 years | |
| Frank G. Pilkiewicz | M | 77 |
Adgero Biopharmaceuticals Holdings, Inc.
 Adgero Biopharmaceuticals Holdings, Inc. Medical SpecialtiesHealth Technology Adgero Biopharmaceuticals Holdings, Inc. a biopharmaceutical company. It focuses on the development of photodynamic therapy for the treatment of rare, unmet medical needs, with particular emphasis on orphan cancer indications. The firm offers candidate, REM-001 therapy, consists of three parts, a laser light source, a light delivery device and the drug REM-001. The company is headquartered inv Princeton, NJ. | - |
| Murray Brennan | M | 84 |
ZIOPHARM, Inc.
| 14 years |
| Alan Dunton | M | 70 | - | |
| Douglas A. Abel | M | 62 | 6 years | |
| Lynn M. Ferrucci | F | - | 9 years | |
| Wyche Fowler | M | 83 |
ZIOPHARM, Inc.
| 14 years |
| Robert Morgan | M | - | - | |
| Kevin Lafond | M | 68 | 12 years | |
| Caesar Belbel | M | 64 | 7 years | |
| Evan S. Melrose | M | 54 | 3 years | |
| Steven Bloom | M | 63 | 6 years | |
| Brian Schwartz | M | 52 | - | |
| Laurence Cooper | M | 59 | 6 years | |
| Barry Jones | M | 74 | - | |
| Craig Tooman | M | 58 | 4 years | |
| Timothy M. Ruane | M | 59 | - | |
| Michael V. Novinski | M | 66 | 4 years | |
| Jacob M. Plotsker | M | 56 | - | |
| Rick Anderson | M | 63 | 3 years | |
| Roman Perez-Soler | M | 70 |
Adgero Biopharmaceuticals Holdings, Inc.
Adgero Biopharmaceuticals Holdings, Inc. Medical SpecialtiesHealth Technology Adgero Biopharmaceuticals Holdings, Inc. a biopharmaceutical company. It focuses on the development of photodynamic therapy for the treatment of rare, unmet medical needs, with particular emphasis on orphan cancer indications. The firm offers candidate, REM-001 therapy, consists of three parts, a laser light source, a light delivery device and the drug REM-001. The company is headquartered inv Princeton, NJ. | - |
| Carlo Casulo | M | - |
Paramount BioCapital, Inc.
Paramount BioCapital, Inc. Investment ManagersFinance Paramount BioCapital, Inc. is an alternative investment manager. The private company is based in New York, NY and has subsidiaries in the United States. | 2 years |
| J. Kris Piper | M | - | - | |
| Francois Lebel | M | 72 | 5 years | |
| Michelle Y. Carroll | F | - | - | |
| Kathleen McDede | F | - | - | |
| Robert O’Holla | M | 72 | 7 years | |
| Anthony J. Yost | M | 65 | 7 years | |
| Jason Amello | M | 55 | 1 years | |
| Daria M. Palestina | F | - | - | |
| David Shimko | M | 63 | 1 years | |
| Mike M. Goldberg | M | 65 | 17 years | |
| Neil Herskowitz | M | 67 | 11 years | |
| John Harkey | M | 63 | 14 years | |
| Mark Rachesky | M | 65 | 15 years | |
| Randal Kirk | M | 70 | 7 years | |
| Nicholas J. Rossettos | M | - | - | |
| J. Lobell | M | 61 |
Paramount BioCapital, Inc.
Paramount BioCapital, Inc. Investment ManagersFinance Paramount BioCapital, Inc. is an alternative investment manager. The private company is based in New York, NY and has subsidiaries in the United States. | 4 years |
| Stephen Rocamboli | M | 52 |
Paramount BioCapital, Inc.
Paramount BioCapital, Inc. Investment ManagersFinance Paramount BioCapital, Inc. is an alternative investment manager. The private company is based in New York, NY and has subsidiaries in the United States. | 8 years |
| Richard Steinhart | M | 66 | 8 years | |
| Sandra C. Heine | F | 62 | 11 years | |
| Gary Fragin | M | 77 |
ZIOPHARM, Inc.
| 6 years |
| Timothy Patrick Lynch | M | 54 | 3 years | |
| Brian Levy | M | 72 | 4 years | |
| Allen Bloom | M | 80 |
Adgero Biopharmaceuticals Holdings, Inc.
Adgero Biopharmaceuticals Holdings, Inc. Medical SpecialtiesHealth Technology Adgero Biopharmaceuticals Holdings, Inc. a biopharmaceutical company. It focuses on the development of photodynamic therapy for the treatment of rare, unmet medical needs, with particular emphasis on orphan cancer indications. The firm offers candidate, REM-001 therapy, consists of three parts, a laser light source, a light delivery device and the drug REM-001. The company is headquartered inv Princeton, NJ. | - |
| Malcolm Morville | M | 78 | - | |
| Howard M. Pack | M | 104 | 22 years | |
| Mark Thornton | M | - | 1 years | |
| Elliot M. Maza | M | 68 | 3 years | |
| Michael King | M | 63 | 1 years | |
| John Chen | M | 46 |
Paramount BioCapital, Inc.
Paramount BioCapital, Inc. Investment ManagersFinance Paramount BioCapital, Inc. is an alternative investment manager. The private company is based in New York, NY and has subsidiaries in the United States. | - |
| Stephen K. Carter | M | 85 | 6 years | |
| John L. Mattana | M | 95 | 11 years | |
| Michael Perelman | M | - | - | |
| Hagop Youssoufian | M | 67 | 2 years | |
| Laura Edgerly-Pflug | F | 60 |
Adgero Biopharmaceuticals Holdings, Inc.
Adgero Biopharmaceuticals Holdings, Inc. Medical SpecialtiesHealth Technology Adgero Biopharmaceuticals Holdings, Inc. a biopharmaceutical company. It focuses on the development of photodynamic therapy for the treatment of rare, unmet medical needs, with particular emphasis on orphan cancer indications. The firm offers candidate, REM-001 therapy, consists of three parts, a laser light source, a light delivery device and the drug REM-001. The company is headquartered inv Princeton, NJ. | 3 years |
| Ronald Zesch | M | - | - | |
| M. Cristina Castelli | M | - | - | |
| Mitchell H. Friedlaender | M | 78 | 12 years | |
| Malcolm Hoenlein | M | 80 | 6 years | |
| Carlos DeLecea | M | - | - | |
| Kenneth Moch | M | 69 | 1 years | |
| Jun Lin Ho | F | 45 | - | |
| Michael E. Black | M | - | - | |
| Leonard M. C. Firestone | M | - | 2 years | |
| Franklin Berger | M | 74 | - | |
| Robert Levenson | M | 82 | 7 years | |
| George Abercrombie | M | 69 | - | |
| Brian L. Hamilton | M | 76 | 1 years | |
| Steven M. Dinh | M | 69 | 8 years | |
| Alan V. Gallantar | M | - | 2 years | |
| Jon Saxe | M | 88 | 16 years | |
| Scott A. Katzmann | M | 67 |
Paramount BioCapital, Inc.
Paramount BioCapital, Inc. Investment ManagersFinance Paramount BioCapital, Inc. is an alternative investment manager. The private company is based in New York, NY and has subsidiaries in the United States. | 18 years |
| Jane M. Maida | F | 68 |
Adgero Biopharmaceuticals Holdings, Inc.
Adgero Biopharmaceuticals Holdings, Inc. Medical SpecialtiesHealth Technology Adgero Biopharmaceuticals Holdings, Inc. a biopharmaceutical company. It focuses on the development of photodynamic therapy for the treatment of rare, unmet medical needs, with particular emphasis on orphan cancer indications. The firm offers candidate, REM-001 therapy, consists of three parts, a laser light source, a light delivery device and the drug REM-001. The company is headquartered inv Princeton, NJ. | - |
| Alan G. Harris | M | 72 | 1 years | |
| Charles H. Abdalian | M | 73 | 2 years | |
| David F. Heniges | M | 80 | 7 years | |
| Colin Scott | M | 72 | 1 years | |
| Anders Paul Wiklund | M | 84 | 12 years | |
| Barbara Wallner | M | - | - | |
| Joan Pons Gimbert | M | 74 | 4 years | |
| Janice Stevens | F | - | 3 years | |
| M. Gary I. Riley | M | 81 | - | |
| Patrick J. Osinski | M | - | - | |
| Amy Mendel | F | 44 | 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Tim McInerney
- Personal Network
